Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?

BACKGROUND: Both dose-escalated external beam radiotherapy (DE-EBRT) and androgen deprivation therapy (ADT) improve the outcomes in patients with intermediate-risk prostate cancer. Despite this, there are only few reports evaluating DE-EBRT for patients with intermediate-risk prostate cancer receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakespeare, Thomas P, Wilcox, Shea W, Aherne, Noel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806761/
https://www.ncbi.nlm.nih.gov/pubmed/27073327
http://dx.doi.org/10.2147/OTT.S102327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806761/
https://www.ncbi.nlm.nih.gov/pubmed/27073327
http://dx.doi.org/10.2147/OTT.S102327

Ejemplares similares